NDC 68001-540-36
Bortezomib 3.5 mg/1
Bortezomib · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Bortezomib is a injection, powder, lyophilized, for solution containing bortezomib at a strength of 3.5 mg/1. Manufactured by BluePoint Laboratories.
Key Facts
- Brand Name
- Bortezomib
- Generic Name
- Bortezomib
- NDC Code (Package)
68001-540-36- NDC Code (Product)
68001-540- Manufacturer
- BluePoint Laboratories
- Strength
- 3.5 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA210824
- Drug Class
- Proteasome Inhibitor [EPC]
- Marketing Start
- 05/16/2022
Recall History
No Recall HistoryView Full Drug Page
Bortezomib — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.